BrainXell, Inc.

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more.

Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.

Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

Founded in 1974, Bioanalytical Systems, Inc. (BASi®) is a publicly traded, global company headquartered in West Lafayette, Indiana, that provides contract research services and sophisticated, niche instrumentation to the life sciences industry, primarily in drug research, discovery, and development in commercial and
academic settings. BASi® also provides critical testing services for biotech and the rapidly growing generic and biosimilars drug sectors. For four decades, BASi® has established itself as an industry leader in contract research and as a resource for instrumentation that meets the demanding requirements of today’s research labs. The world’s leading pharmaceutical companies, academic centers, and startup companies in drug development
and biotech rely on BASi’s expertise in the demanding fields like
electrochemistry, immunochemistry, preclinical and reproductive toxicology, pathology, in-vivo fluid sampling and DMPK. Since 2018, BASi has acquired three companies and in doing so, expanded the capabilities of the contract research services offered. These acquisitions initiated a branching of BASi Inc. into two divisions: Inotiv and BASi Research Products.
Whether it is with Inotiv contract research services or with BASi’s Research Products’ innovative product line, we remain committed to providing customer-focused solutions to help you meet your research goals!

CSBio is a leading peptide and peptide synthesizer manufacturing company located on the edge of Silicon Valley in Menlo Park, California. Since 1993, CSBio has been providing high quality custom peptides, cGMP peptides and automated peptide synthesizers to the global biotech community. Our peptide products and peptide synthesis equipment can be found in peptide production laboratories and pharmaceutical companies worldwide.

CSBio now also offers solid phase peptide synthesis resins as well as high quality Fmoc and Boc protected amino acids for use in both R&D and cGMP peptide manufacturing. Our state of the art cGMP manufacturing facility provides cGMP peptides for preclinical and clinical programs and our commercialization and regulatory teams can take you from toxicology studies through market commercialization. Our product line also includes a complete list of generic peptide APIs including the most widely used peptide APIs in the industry. Whatever your peptide requirements, CSBio can assist you in reaching your ultimate goals by offering high quality products and world class support.

CH Technologies is a partner to the scientific community, to create the innovative tools capable of supporting the advancement of inhalation toxicology research. We stand ready to offer complete solutions that harness our devotion to the sciences and our openness to re-engineering our product concepts to perfectly suit the needs of scientists working to expand the boundary of man's knowledge.

In the field of toxicology, whether inhalation, respiratory or test atmosphere generation for in-vivo and in-vitro research, the microscopic properties of particles (respirable or non-respirable), far exceed the power of our perception. Despite their small size, the impacts that they have on our lives and global environment are profound. Combining the latest technology with our established expertise in aerosol science, we work beyond the current capabilities of research to push the boundaries of particle, gas and vapor toxicology.

This is why here at CH Technologies, we believe the small things count. Our attention to detail has long been a mark of quality on our products, resulting not only in publications, but lasting relationships with our customers.